July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Kathy Chung Ying Chan Has Been Appointed as Group Leader of Theranostics at ICR
May 24, 2025, 17:04

Kathy Chung Ying Chan Has Been Appointed as Group Leader of Theranostics at ICR

The Institute of Cancer Research shared a post on LinkedIn:

“Radiopharmaceuticals – a groundbreaking approach combining diagnostic imaging with targeted radiotherapy – is emerging as a powerful tool in personalised cancer treatment.
Dr Kathy Chung Ying Chan, newly appointed Group Leader of the Experimental and Translational Theranostics Group at the ICR, is developing novel radiopharmaceuticals that both detect and treat tumours with high precision. Her lead compound, KK02, has shown strong potential in preclinical models and may one day help treat aggressive cancers such as prostate, pancreatic, and breast cancer.
Early results demonstrate effective tumour targeting with minimal side effects – an essential step towards safer, more effective therapies. Dr Chan’s work also explores the potential of combining radiopharmaceuticals with immunotherapy to improve outcomes for hard-to-treat cancers. Read more about Dr Chan’s research, and its implications for the future of oncology.”

Read further.

More posts featuring ICR.